Idexx Laboratories Inc /De reports $4.3 billion revenue for fiscal year ended December 31, 2025, up 10.4%

ยท IDXX

Idexx Laboratories Inc /De reported revenue of $4.3 billion for the year ended December 31, 2025, an increase of 10.4% from the previous year ($3.9 billion).

For the same period it posted net income of $1.06 billion, up 19.3%, or $13.08 per diluted share (10.67 a year earlier).

That is a net margin of 24.6%.

On Sanad's AAOIFI Standard 21 screen, Idexx Laboratories Inc /De is currently compliant: interest-bearing debt is 0.7% of market capitalisation (limit 30%), and impure income is 0.1% of revenue (limit 5%).

Source: 10-K filed with the U.S. Securities and Exchange Commission on February 20, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Idexx Laboratories Inc /De news